Innovative therapeutic cancer vaccine PDC(∗)lung01 with or without anti-PD-1: an open-label, dose-escalation phase I/II study in non-small-cell lung cancer
创新型治疗性癌症疫苗PDC(∗)lung01联合或不联合抗PD-1抗体：一项针对非小细胞肺癌的开放标签、剂量递增I/II期研究
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105844
Vansteenkiste, J; Demedts, I; Cuppens, K; Pons-Tostivint, E; Wauters, E; Borm, F J; Sibille, A; Colinet, B; Pérol, M; Theelen, W S M E; Biesma, B; Van De Kerkhove, C; Buchmeier, E; Althoff, F C; Derijcke, S; Moro-Sibilot, D; Laulagnier, K; Halioua, E; Levy, L; Genin, M; Michel, S; Dedry, C; Duchayne, C; Collodoro, M; Renard, F; Adriaenssens, S; De Vos, B; Cantero, F; Plumas, J; Skrzypski, M
